CTRI/2021/03/031826Not yet recruiting未知
Reduction in low density lipoprotein cholesterol (LDL-C) with statin therapy among south Indian patients.
Kasturba Medical College Manipal Manipal Academy of Higher Education Manipal0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- 未知
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
Inclusion Criteria
- •Patients aged > 18 years with ischemic heart disease, naïve to statins, and underwent angioplasty between October 2020 to September 2021.
Exclusion Criteria
- •1.Patients who are unstable, having severe pulmonary edema or very sick and old patients.
- •2.Patients who refuse to give consent.
Investigators
Similar Trials
Completed
Not Applicable
Intensive LOwering of BlOod low-density lipoprotein ChOlesterol with statin + ezetimibe therapy improves cardiac function after Percutaneous coronary intervention in patients with coronary stenting in Fukuoka-II (LOBOCOP-II)Ischemic heart diseaseJPRN-UMIN000001782Heart/vascular internal medicine,fukuoka university200
Unknown
Not Applicable
Low-density Lipoprotein Cholesterol Reduction With State-of-the-art Therapy in Secondary Prevention and Major Cardiovascular Adverse Events: Republic of Srpska RegistryDyslipidemiasAcute Coronary SyndromeNCT05081336University Clinical Centre of Republic of Srpska500
Completed
Not Applicable
Study of reducing of serum LDL-cholesterol levels by ingestion of test supplement -A randomized, double blinded, placebo controlled, parallel group comparison studyHealthy subjectsJPRN-UMIN000043559FANCL Corporation90
Completed
Phase 3
Efficacy and Safety Evaluation of Alirocumab in Patients With Heterozygous Familial Hypercholesterolemia or High Cardiovascular Risk Patients With Hypercholesterolemia on Lipid Modifying Therapy (ODYSSEY JAPAN)HypercholesterolemiaNCT02107898Sanofi216
Completed
Phase 3
Efficacy and Safety of Alirocumab in Patients With Hypercholesterolemia Not Adequately Controlled With Non-statin Lipid Modifying Therapy or the Lowest Strength of StatinHypercholesterolemiaNCT02584504Sanofi163